We are live on ! Find out more
CP

Catalys Pacific Portfolio holdings

AUM $229M
1-Year Est. Return 100.3%
This Fund
S&P 500
This Quarter Est. Return
-0.54%
1 Year Est. Return
+100.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$229M
AUM Growth
-$1.26M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLYS icon
1
Mineralys Therapeutics
MLYS
$2.48B
$213M 92.94%
7,903,838
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$605M
$16.2M 7.06%
1,493,854

Similar funds

Catalys Pacific's Q2 2026 Portfolio in Review

As of Q2 2026, Catalys Pacific held 2 positions worth $229M, down 0.55% from $231M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. Catalys Pacific opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Catalys Pacific's ten largest holdings make up 100% of its $229M portfolio in Q2 2026.
  • Catalys Pacific opened 0 new positions and closed 0 in Q2 2026.
  • Catalys Pacific's portfolio value fell 0.55% quarter-over-quarter to $229M.

Based on Catalys Pacific's 13F filing for Q2 2026, filed 5 Aug 2026.